Mysayoka 15units Injection
Marketer
Sayoka Pharmaceutical (OPC) Pvt Ltd
Salt Composition
Bleomycin (15units)
Overview Mysayoka 15units Injection
Oncaspare 15-unit injection is a cancer treatment medication effective against various cancers, including cervical, oral, nasopharyngeal, paranasal sinus, laryngeal, esophageal, and cutaneous cancers. Its mechanism involves disrupting cancerous cell proliferation, ultimately leading to their destruction. Oncaspare 15-unit injection can be administered alone or in conjunction with other therapies. Always administered under a healthcare professional's supervision, self-medication is strictly prohibited. Dosage and frequency are determined by your physician based on your specific condition and may be adjusted. Adhere strictly to prescribed usage; improper administration or overdose can lead to severe adverse reactions. Therapeutic benefits may not be immediately apparent, potentially requiring weeks or months; discontinue use only upon your doctor's instruction. Alcohol consumption should be avoided due to increased liver damage risk. Common side effects include pyrexia, anorexia, alopecia, weight loss, nausea, interstitial pneumonia, dyspnea, and cough. Report persistent or worsening symptoms to your physician; mitigation strategies may be available. As a potent medication, serious adverse events are possible. It can compromise immune function and potentially affect hematological, hepatic, or renal systems. Regular blood tests will be recommended to monitor these parameters. Prior to treatment, disclose any pre-existing gastrointestinal, hepatic, or renal conditions, as well as any antimicrobial medications. Significant drug interactions are possible; therefore, inform your physician of all medications being taken. This medication is contraindicated during pregnancy and lactation due to potential fetal harm. Pregnancy or fathering a child should be avoided for several months post-treatment. Pre- and post-treatment monitoring may involve blood tests, radiographic imaging, and physical examinations.
Primary Ingredients of Mysayoka 15units Injection
No text provided to rephrase.
Uses of Mysayoka 15units Injection
Cancers of the cervix, head and neck (including mouth, nose, and throat), and skin.
Major Benefits of Mysayoka 15units Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Mysayoka 15units Injection:
- Fever
- Hair loss
- Interstitial pneumonia
- Loss of appetite
- Low blood platelets
- Nail discoloration
- Nausea
- Pulmonary fibrosis
- Rigors
- Scratch dermatitis
- Skin pigmentation
- Stomatitis (Inflammation of the mouth)
- Vomiting
- Weight loss
How to use Mysayoka 15units Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Mysayoka 15units Injection works:
OncoSay 15-unit injection is a cancer therapeutic agent. Its mechanism of action involves DNA disruption within malignant cells, thereby inhibiting their proliferation and growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Mysayoka 15-unit Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Mysayoka 15-unit Injection during pregnancy poses a confirmed risk to the fetus. Its use should be avoided except in exceptional circumstances where a physician deems the potential benefits outweigh the known hazards to the mother's life. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Administering Mysayoka 15-unit Injection while breastfeeding is potentially hazardous. Available human data indicates a possibility of the medication transferring to breast milk, posing a risk to the infant.
DrivingUNSAFE
Administration of Mysayoka 15-unit Injection may induce adverse reactions that could impair driving capabilities. Similar to $med_name, fatigue or weakness following treatment has been reported in a small number of patients, potentially affecting their ability to operate a vehicle.
KidneyCAUTION
Administering Mysayoka 15-unit Injection requires careful consideration in individuals with impaired renal function. Dosage modification of Mysayoka 15-unit Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Mysayoka 15-unit Injection in individuals with hepatic impairment appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Mysayoka 15units Injection :
NA
Facts to Know About Mysayoka 15units Injection
| Label | Value |
|---|---|
| Chemical Category | Cancer-Fighting Antibiotics |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Cytotoxic alkaloids |
3,018 People bought this recently